Search results
Wall Street Analysts Believe Anavex Life Sciences (AVXL) Could Rally 238%: Here's is How to Trade
Zacks via Yahoo Finance· 2 years agoThe average of price targets set by Wall Street analysts indicates a potential upside of 238.3% in...
Anavex Life Sciences (AVXL) Upgraded to Strong Buy: Here's Why
Zacks via Yahoo Finance· 3 months agoAnavex Life Sciences (AVXL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing...
Anavex (AVXL) Up 12% on Regulatory Update for Alzheimer's Drug
Zacks via Yahoo Finance· 5 months agoAnavex (AVXL) announces an encouraging regulatory update for its investigational candidate,...
Anavex (AVXL): Strong Industry, Solid Earnings Estimate Revisions
Zacks via Yahoo Finance· 4 months agoOne stock that might be an intriguing choice for investors right now is Anavex Life Sciences Corp....
Anavex Life Sciences Corp. (NASDAQ:AVXL) Is Expected To Breakeven In The Near Future
Simply Wall St. via Yahoo Finance· 8 months agoWith the business potentially at an important milestone, we thought we'd take a closer look at...
Anavex (AVXL) Falls 35% on Mixed Rett Syndrome Study Results
Zacks via Yahoo Finance· 4 months agoAnavex (AVXL) falls 35% on mixed results from the mid to late-stage study of 30 mg ANAVEX2-73 for...
Is Anavex Life Sciences Stock a Buy Now?
Motley Fool· 1 year agoAnavex Life Sciences (NASDAQ: AVXL) is a small-cap stock with big ambitions. It has a potential Alzheimer's treatment that fared well in recent trials...
Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why
Motley Fool· 1 year agoCan a biotech stock that's down by about 40% in the last month have any chance of rallying to...
Wall Street Thinks This Small-Cap Stock Can Quadruple in Value
Motley Fool· 1 year agoSmall-cap stocks with promising growth prospects can have substantial upside. But they often come...
